Detalhe da pesquisa
1.
Updated progression-free survival and final overall survival with maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial.
Int J Gynecol Cancer
; 34(4): 550-558, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38129136
2.
LION-PAW (lymphadenectomy in ovarian neoplasm) sexual function assessment: a prospective sub-study of the LION trial.
Int J Gynecol Cancer
; 30(10): 1548-1553, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32938723
3.
Clinical Outcome of Neoadjuvant Radiochemotherapy in Locally Advanced Cervical Cancer: Results of an Open Prospective, Multicenter Phase 2 Study of the North-Eastern German Society of Gynecological Oncology.
Int J Gynecol Cancer
; 27(3): 500-506, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28187089
4.
Genome-wide association analyses of ovarian cancer patients undergoing primary debulking surgery identify candidate genes for residual disease.
NPJ Genom Med
; 9(1): 19, 2024 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38443389
5.
Adjuvant capecitabine versus nihil in older patients with node-positive/high-risk node-negative early breast cancer receiving ibandronate - The ICE randomized clinical trial.
Eur J Cancer
; 194: 113324, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37797387
6.
Pazopanib with Topotecan weekly for patients with platinum-resistant or intermediate-sensitive recurrent ovarian cancer: results of a multicentre, open label phase I/II study (TOPAZ).
J Cancer Res Clin Oncol
; 149(10): 7637-7649, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37000264
7.
The Endocrine Treatment Landscape for Patients with HR+ HER2- Early-stage Breast Cancer in Germany Before the Introduction of CDK4/6 Inhibitor Therapy - A Real-World Analysis.
Geburtshilfe Frauenheilkd
; 83(9): 1127-1137, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37942358
8.
Optimal Treatment Duration of Bevacizumab as Front-Line Therapy for Advanced Ovarian Cancer: AGO-OVAR 17 BOOST/GINECO OV118/ENGOT Ov-15 Open-Label Randomized Phase III Trial.
J Clin Oncol
; 41(4): 893-902, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36332161
9.
Randomized phase II trial of carboplatin and paclitaxel with or without lonafarnib in first-line treatment of epithelial ovarian cancer stage IIB-IV.
Gynecol Oncol
; 126(2): 236-40, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22564713
10.
Bevacizumab May Differentially Improve Prognosis of Advanced Ovarian Cancer Patients with Low Expression of VEGF-A165b, an Antiangiogenic VEGF-A Splice Variant.
Clin Cancer Res
; 28(21): 4660-4668, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36001383
11.
Effect of neoadjuvant anthracycline-taxane-based chemotherapy in different biological breast cancer phenotypes: overall results from the GeparTrio study.
Breast Cancer Res Treat
; 124(1): 133-40, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20697801
12.
Dilution of Molecular-Pathologic Gene Signatures by Medically Associated Factors Might Prevent Prediction of Resection Status After Debulking Surgery in Patients With Advanced Ovarian Cancer.
Clin Cancer Res
; 26(1): 213-219, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31527166
13.
Topotecan and carboplatin in patients with platinum-sensitive recurrent ovarian cancer. Results of a multicenter NOGGO: phase I/II study.
Cancer Chemother Pharmacol
; 62(3): 393-400, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-17922272
14.
Comparative evaluation of the treatment efficacy of suberoylanilide hydroxamic acid (SAHA) and paclitaxel in ovarian cancer cell lines and primary ovarian cancer cells from patients.
BMC Cancer
; 6: 183, 2006 Jul 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-16834771
15.
Non-pegylated liposomal doxorubicin for patients with recurrent ovarian cancer: A multicentric phase II trial.
Oncol Lett
; 12(2): 1211-1215, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27446420
16.
German adjuvant intergroup node-positive study: a phase III trial to compare oral ibandronate versus observation in patients with high-risk early breast cancer.
J Clin Oncol
; 31(28): 3531-9, 2013 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23980081
17.
A prospective multicenter study of treosulfan in elderly patients with recurrent ovarian cancer: results of a planned safety analysis.
J Cancer Res Clin Oncol
; 138(8): 1413-9, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22526159
18.
Topotecan Weekly Versus Conventional 5-Day Schedule in Patients With Platinum-Resistant Ovarian Cancer: a randomized multicenter phase II trial of the North-Eastern German Society of Gynecological Oncology Ovarian Cancer Study Group.
J Clin Oncol
; 29(2): 242-8, 2011 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-21115872
19.
Selective pretreatment diagnostic imaging for detecting remote metastases in patients with endometrial cancer.
Onkologie
; 29(3): 85-9, 2006 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-16514268